Tag: Vaccines
Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season
Vaccine effectiveness against medically attended outpatient acute respiratory infection associated with A(H3N2) was 16 percent
COVID-19 Vaccination Coverage Higher in Urban Versus Rural Counties
Completion of primary series was higher in urban than rural counties; receipt of booster similarly low in both urban, rural counties
In Reversal, WHO Now Supports COVID-19 Boosters
Number of studies show that booster doses help restore weakening immunity and protect against severe COVID-19
Vaccination Reduces Incidence of SARS-CoV-2 Among Adolescents
Vaccine effectiveness was 87.8 and 89.1 percent against documented and symptomatic infection, respectively
Physician’s Briefing Weekly Coronavirus Roundup
Vaccine Effectiveness Lower for Teens With Predominant Omicron
VE increased for adolescents aged 16 to 17 years at seven or more days after a third booster dose during omicron predominance
Homologous Pfizer-BioNTech Booster Safe for Adolescents
Reactions to booster occur with similar frequency as after receipt of second vaccine dose, generally mild to moderate
Vaccination Ups Infection-Acquired Immunity Against SARS-CoV-2
Two doses of BNT162b2 vaccine linked to high short-term protection against infection, which wanes after six months
Vaccine Rollout Linked to Drop in Severe COVID-19 in Dialysis Patients
And, patients on maintenance dialysis who received COVID-19 vaccination had decreasing antibody titers over time
